Proteolytic cleavage of the amyloid precursor protein (AβPP) by secretases leads to extracellular release of amyloid β (Aβ) peptides. Increased production of Aβ 42 over Aβ 40 and aggregation into oligomers and plaques constitute an Alzheimer's disease (AD) hallmark.
INTRODUCTION
Proteolytic processing of AβPP by β-and γ-secretases leads to the production of various Aβ peptides, including the 42-amino acid form (Aβ 42 ) which plays a crucial role in AD [1] [2] [3] . The action of β-secretase first leads to a soluble fragment (sAβPP) and a membrane-bound fragment (βCTF, β-carboxyl-terminal fragment). γ-Secretase then cleaves the βCTF, leading to the generation of Aβ peptides of various lengths. Aβ peptides tend to aggregate as extracellular oligomers and ultimately as plaques, one of the clinical hallmarks of AD.
Aβ 40 is the most abundantly produced Aβ peptide. Considerable data indicates that generation of the aggregation-prone Aβ 42 strongly correlates with the onset and development of AD. In early-onset AD (EOAD) (<1% of all cases), mutations in AβPP, or the γ-secretase subunits PSEN1 & PSEN2 [review in 4] , all lead to enhanced Aβ 42 production and/or increased Aβ 42 /Aβ 40 ratio, a critical factor in AD pathology initiation [5] . Increased Aβ 42 /Aβ 40 ratio is also found in brain tissue in late-onset AD (LOAD) (>99% of AD cases). Aβ 42 is more toxic than Aβ 40 , a consequence of its higher stability and strong tendency to oligomerize and to aggregate in plaques [6] [7] [8] . Aβ 43 is also enriched in the brain of AD patients and has been reported as a toxic, aggregation-prone amyloid, inducing strong AD phenotypes in mice [9] [10] [11] [12] .
We recently reported that some tri-substituted purines, the aftins (Amyloid β FortyTwo Inducers), trigger a robust, secretases-dependent increase in extracellular Aβ 42 production in cultured cells [13] [14] . Under these conditions Aβ 38 levels dropped while Aβ 40 remained relatively stable. These results suggest that (i) such molecules might constitute new pharmacological tools to investigate the mechanisms underlying the increased Aβ 42 /Aβ 40 ratio observed in AD, (ii) these molecules might contribute to generate a chemically induced animal model of AD [15] and (iii) some simple, low molecular weight (LMW) products in our environment might shift the Aβ 42 /Aβ 40 ratio similarly to what is seen in AD patients and might thus contribute to the development, acceleration or even initiation of LOAD.
We therefore screened for potential Aβ 42 -inducing molecules in libraries of HCE products [16] [17] [18] [19] [20] [21] . We here report that a subset of the widely used triazine herbicides is able to shift Aβ production towards longer, aggregation-prone amyloid peptides (Aβ 42 /Aβ 43 ) at the expense of shorter variants (Aβ 37 , Aβ 38 , Aβ 40 ). In addition, production of the shorter Aβ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] and Aβ 1-17 peptides, the generation of which is dependent on β-and γ-secretase activities [22, 23] , was also enhanced. This effect is observed in various cell lines, primary neuron cultures and neurons differentiated from iPSCs obtained from healthy controls or AD patients.
Triazines shift the cleavage pattern of alcadeinsα, another γ-secretase substrate [24] [25] [26] [27] [28] , in a way similar to the AβPP cleavage shift, suggesting a direct effect on γ-secretase rather than on its substrates. Altogether these data support our hypothesis that the HCE contains products able to modulate γ-secretase activity towards the production of high MW, aggregation-prone, AD-associated amyloids. Such products could be qualified as potential "Alzheimerogens" (name by analogy with "carcinogens"). Their identification and regulation might constitute a key step in AD prevention.
MATERIAL & METHODS
Material and methods are described in full in the SI section. They include:
1. Triazines and other reagents. 
Cell viability assay.

RESULTS
Screening the HCE reveals triazines as Aβ 42 inducers
A library of 3500+ LMW (<1000 daltons) products representative of the HCE was assembled. All compounds were tested for their ability to trigger extracellular Aβ 42 production by N2a cells stably expressing AβPP695 (N2a-APP695), at 1, 10 and 100 µM (data not shown. A dose-dependent effect was often seen with the active compounds). In parallel, cell viability assays were run to assess cell survival at these concentrations. The vast majority of products were unable to induce Aβ 42 production. Among the few active products, we identified several triazines, a class of products which are widely used as herbicides, antifouling agents or flame retardants [reviews in 29] . We next tested a library of 37 triazines representing the most produced triazines worldwide (1-37, SI, Table S1 ), along with Aftin-5 (38) as a positive control, on both N2a-APP695 and CHO-7PA2 cells stably expressing AβPP751 (CHO-7PA2-APP751), for their ability to trigger Aβ 42 production at 1, 10 and 100 µM (SI , Table S2 ) (Fig. 1A) .
Six triazines were found to induce more than a 3-fold change in Aβ 42 levels (Fig. 1A, 1B): ametryn, prometryn, dipropetryn, terbutryn, cybutryne, dimethametryn. As observed with aftins [13, 14] , Aβ 42 production was strongly inhibited by β-(inhibitor IV) and γ-secretases (BMS 299897, DAPT) inhibitors and by a γ-secretase modulator ('Torrey Pines' compound) (the latter induces a dose-dependent increase in Aβ 38 and a decrease in Aβ 42 and Aβ 40 ) [30, 31] (Fig. 1C) . Similarly, Aβ 38 production was strongly reduced, while Aβ 40 levels were only modestly affected as measured by ELISA (data not shown) and by mass spectrometry (Fig. 2) . Most of the triazines are metabolized in the environment and by organisms. We thus tested some of the cybutryne/terbutryn metabolites (39-44) (SI, Fig. S1) for their ability to trigger Aβ 42 production in N2a-APP695 and CHO-7PA2 cells. None of the tested metabolites was active as an inducer of Aβ 42 production (data not shown). We next tested a library of 236 triazines that had been synthesized as affinity chromatography reagents, for their ability to induce Aβ 42 production [32, 33] . Twenty-one of these (45-65) showed significant enhancement of Aβ 42 production (SI, Table S3 ), showing that Aβ 42 induction is an intrinsic property of some triazines. Affinity chromatography attempts with immobilized triazines did not allow us to purify specific targets, probably because of unselective hydrophobic interactions and low level expression of the specific targets (data not shown).
Results were confirmed with HEK293 stably expressing AβPPsw (data not shown) and neurons derived from human iPSCs (see below). We also analyzed the effects of triazines on primary neuronal cultures prepared from E18 OFA rat embryo brains. Neurons were exposed to 100 µM of each triazine for 18 h, and the supernatants were collected for Aβ determination by ELISA assays. The triazines also induce an increase in Aβ 42 production by primary neurons and in the Aβ 42 /Aβ 40 ratios (Fig. 1D) . Aβ 40 production remained relatively stable, while that of Aβ 38 was reduced by all triazines (Fig. 1D ).
Mass spectrometric quantification and profile analysis of induced amyloids
Aβ 38 , Aβ 40 and Aβ 42 were quantified in the supernatants of N2a-APP695 ( Fig. 2A) and CHO-7PA2-APP751 (Fig. 2B ) using LC-MS/MS [34, 35] . Like Aftins [13, 14] , triazines induced a reduction in Aβ 38 levels, a slight increase or modest decrease in Aβ 40 levels and a strong increase in Aβ 42 levels (Fig. 2, bottom) . Aβ 42 /Aβ 40 ratios were strongly increased (Fig. 
2, top).
We next analyzed, by IP-MS, the range of Aβ peptides produced by both cell lines exposed to each of the six triazines and aftin-5. Cell supernatants were collected and Aβ peptides were immunoprecipitated and analyzed using MALDI TOF/TOF [36] . Examples of spectra for cells exposed to terbutryn, aftin-5 and DMSO are provided in Fig. 3 and Fig. S2 (SI). Exposure to triazines increased the production of Aβ 1-17 , Aβ 11-42 , Aβ 5-42 and Aβ , while the production of Aβ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , Aβ 1-27 , Aβ 1-33 , Aβ and Aβ 1-39 was reduced (Fig. 3) . Other amyloid peptides (including Aβ ) showed only modest changes. Aβ 1-43 , a highly neurotoxic amyloid [9] [10] [11] [12] , was undetectable in supernatants of control cells, but strongly induced in aftin-5 and triazine-treated cells.
Neurons differentiated from human iPSCs of AD patient and healthy control
We next tested the effects of aftin-5 and the active triazines on neurons differentiated from human iPSCs derived from a healthy individual (AβPP WT, wild-type) or from a patient with familial AD (AβPP K724N mutation) [37, 38] (Fig. 4) . Neurons from the healthy control were first differentiated for either 4 or 10 weeks before 24 h exposure to 100 µM aftin-5 or terbutryn (Fig. 4A) . Treatment resulted in a 2-3 fold increase in Aβ 42 levels compared to neurons exposed to DMSO. Aβ 40 levels remained essentially unchanged. All six triazines were next tested on neurons derived from the control and the AD patient differentiated for 4 weeks [38, 39] (Fig. 4B ). AβPP K724N neurons produced more Aβ 42 versus Aβ 40 compared to AβPP WT neurons. Addition of aftin-5 or any of the six active triazines resulted in further increase in Aβ 42 production, in both AβPP WT and AβPP K724N neurons.
AβPP sequence requirements for Aβ 42 induction by triazines
To investigate the molecular mechanisms and possible ε cleavage sites requirement for the induced Aβ 42 production, we generated six AβPP truncations (T1-T6) and expressed them transiently in N2a cells (Fig. 5A ). Cells expressing these truncations were then exposed to 100 µM aftin-5 and Aβ 42 production was measured (Fig. 5B) . Full-length (FL) AβPP and the first three truncations displayed enhanced Aβ 42 production (Fig. 5B) . In contrast, the three remaining truncations did not allow enhanced Aβ 42 production when cells were exposed to aftin-5. Cells expressing FL AβPP and truncations T1, T3, T4 were next exposed to 100 µM of each triazine (Fig. 5C ). Although T3 allowed stimulation of Aβ 42 production, T4 did not.
These results reveal a strong AβPP structural requirement for enhanced Aβ 42 production induced by aftin-5 and triazines, which seems to correspond to the ε cleavage sites of AβPP by γ-secretase. At least 10 residues downstream of the Aβ 42 cleavage site are required for the full effect of aftin-5 and triazines.
Triazines and Aftin-5 shift the cleavage pattern of the γ-secretase substrates alcadeins Like AβPP, alcadeins/calsyntenins are sequentially cleaved by secretases, first by α-secretase, leading to N-and C-terminal fragments, the latter being then cleaved by γ-secretase to an intracellular domain and the p3-Alcs peptide, in a way similar to AβPP [25, 27] (Fig.   6A ) (SI, Fig. S3 ). We used HEK293 cells stably expressing full length alcadeinα to investigate the effects of triazines on alcadein cleavage. Alcadeinα is first cleaved on the Nterminal side (two possible sites) followed by cleavage by γ-secretase leading to p3-Alcα35 and p3-Alcα 2N+35, the latter representing the major peptide in cultured cells (Fig. 6A ).
Cleavage at nearby sites (blue arrows) leads to other less abundant peptides. HEK293-alcadeinα cells were grown till 60% confluence and treated with 100 µM aftin-5 or triazines for 24 h. The secreted p3-Alcα peptides were recovered and analyzed by MALDI TOF MS (Fig. 6B) .
Quantification of p3-Alcα peptides showed that, compared to the p3-Alcα peptide profile in vehicle treated cells, concentrations of the main alcadeinα peptide (p3-Alcα 2N+35) and p3-Alc 37 peptide remained stable. In contrast, both p3-Alc 2N+34 and p3-Alc 2N+36 concentrations dropped by ~50% and p3-Alc 2N+38 peptide concentration increased massively (up to 28.1 fold for dimethametryn; 16.8 fold for Aftin-5) (Fig. 6C ).
These results show that, like for AβPP, triazines and aftin induce a shift in the cleavage pattern of Alcadein , another γ-secretase substrate, suggesting that these products are more likely to interact with γ-secretase rather than with its substrates. (2) the mechanism of action is more likely to involve an effect on γ-secretase and/or its microenvironment rather than an interaction with its substrates, as shown by the fact that aftins and triazines also induce a shift in the cleavage pattern of alcadeins, another γ-secretase substrate.
DISCUSSION
Induction of
The AβPP truncation experiments clearly suggest a very specific molecular requirement rather than a global, non-selective effect.
(3) despite extensive proteomics studies (data not shown), we were unable to detect major/significant modifications of protein expression that might be linked to the AβPP cleavage shift induced by triazines, suggesting that RNA or protein synthesis alterations are unlikely involved in the induction of Aβ 42 production. We were also unable to identify a specific target of triazines through affinity chromatography/proteomics approaches, suggesting that either the lipid raft comprising the γ-secretase or rather hydrophobic domains of γ-secretase might constitute the real targets of triazines (and aftins).
"Alzheimerogens" in the HCE?
The Chemical Abstracts Service (CAS) registry, the world's largest chemical database,
contains more than 101 million organic and non-organic substances. About 15,000 novel substances are registered every day (on average one new substance every 2.5 min. since 50 years!) (www.cas.org). The US EPA Toxic Substances Control Act lists over 84,000 chemicals that are manufactured or imported at levels >10 tons per year, not including pesticides, cosmetics, food stuffs and food additives which are covered by other legislations (www.epa.gov). It is estimated that man is exposed to over 85,000 products. The European REACH initiative aims at regulating all products which are produced/imported at >100 tons/year (>1 ton/year by May 2018). All these products, along with all natural substances to which we are exposed from conception to death, constitute the HCE [17, 18, 48, 49].
The impact of environment on health has been known since antiquity. It is therefore no surprise that a small number of products may enter the human body, cross the blood brain barrier (BBB), alter specific molecular pathways in some of the human brain 10 11 neurons and 10 12 glia cells and thereby induce or contribute to specific diseases affecting the central nervous system. Identification of environmental factors involved in neurodegeneration and neurodegenerative diseases is surprisingly still in its infancy [reviews in 50-54]. The nervous system may be exposed to neurotoxic agents acutely (hours, days) or chronically (weeks, years, decades) before disease symptoms appear. Epidemiology studies are particularly difficult for neurodegenerative diseases since causes and effects are often separated by decades. These studies have, therefore, provided only few examples of environmental agents linked to the onset of neurodegenerative diseases. Pesticides, organic solvents, metals and some natural toxins (cyanobacteria) constitute the most frequently proposed neurotoxic agents. Two recently published books [55, 56] review the impact of early age and even in utero exposure to environmental chemical entities on brain development and cognitive abilities.
AD is one of the most prevalent and worrisome neurodegenerative diseases [57] .
EOAD is clearly a genetic disease due to specific AβPP or PSEN1/2 mutations leading to overproduction of Aβ 42 over Aβ 40 . The origin of LOAD (sporadic AD) (>99% of all AD cases) remains a mystery which epidemiological or genome-wide association studies have not solved, the latter having only revealed a few low impact genetic risk factors [58] . 
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Lancet Neurol 13, 330-338. A panel of 236 triazines was selected in a large triazines library constructed as described previously [30, 31] . Twenty products displayed some activity (45-65) (Supplementary Table  S5 ). Five triazines (49, 66-69) bearing a poly-ethylene glycol linker (2, 3 or 4 ethylene glycol moieties) were synthesized by JL and YTC (not shown).
Aftin-5 (38) (Adipogen International, San Diego, CA, USA) was synthesized as previously described [14] . Aftin-5 bearing a poly-ethylene glycol linker (5 ethylene glycol moieties) (70) was synthesized by NO and HG (not shown).
All compounds were solubilized as 100 mM stock solutions in 100% dimethylsulfoxide (DMSO) and diluted just prior use.
The γ-secretase modulator ('Torrey Pines' compound) was synthesized as previously described [14, 30, 31] . DMSO, Nonidet P-40, Tween-20, CHAPSO (3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate), dithiothreitol (DTT), bovine serum albumin (BSA), Na 2 CO 3 , NaHCO 3 , citric acid monohydrate, Na 2 HPO 4 .2H 2 
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phenyl]glycine-1,1-dimethylethyl ester) were obtained from Tocris Bioscience (Lille, France). β-secretase inhibitor IV was from Calbiochem (Molsheim, France). Red and without HEPES. Cells were split routinely every 4/5 days. They were first rinsed with phosphate buffered saline (PBS) (Gibco) and detached from the plate bottom using 4 mL Versene (Gibco) at room temperature (RT) for 3-4 min. Eight mL of fresh medium were added to the cell suspension, and the mix was centrifuged for 3 min at 1,000 rpm. The cell pellet was resuspended in fresh medium before seeding (1/10 dilution) in new flasks.
Cell cultures: cell lines, primary neuron cultures, iPSCs-derived neurons & HEK293-alcadeinα cells
Primary Rat Neuronal Cultures
Primary neuronal cultures were prepared from E18 OFA rats embryos brains (Charles River laboratories, L'Arbresle, France). All procedures were performed according to European law (EEC 86/609) and were approved by the local veterinary authorities (N° 12037). Primary cultures of cortical neurons were prepared according as described [65] with minor modifications. Dissociated neurons were plated onto poly-D-lysine (50 µg/mL) coated coverslips (14 mm diameter, Marienfeld GmbH, Lauda-Königshofen, Germany) into 12 wells culture plates (Costar, Corning NY, USA) at 10 5 cells/cm 2 for cortical neurons. All experiments were performed at 15 days in vitro (DIV). Briefly, cortices were dissected in Hank's Balanced Salt Solution (HBSS) containing 5 mM glucose (dissection medium). The medium was replaced 0.05% trypsin in 0.5 mM EDTA (Life Technologies, Grand island, NY, USA). Cortices were digested separately for 15 min at 37°C. After removing the trypsin, cortices were washed in dissection medium, and incubated in HBSS containing trypsin inhibitor (2 mg/mL, Sigma Aldrich, St Quentin Fallavier, France) and DNAse I (0.05%, Sigma) for 3 minutes at 37°C. Cortices were washed in dissection medium, taken up in few mL of dissection medium and gently triturated by passing through a 1 mL ART® filter tip. Cells were counted and seeded at a density of 10 5 cells/cm 2 into 12 wells culture plates (Costar) in plating medium (DMEM medium containing 10% heat-inactivated horse serum (Life Technologies)). Wells contained acid-washed glass coverslips (14 mm diameter, Marienfeld) which had been precoated with 50 µg/mL poly-D-lysine (Sigma). Cultures were left to attach at 37°C with 5% CO 2 . After 2 h, the plating medium was replaced with Neurobasal containing 2 mM glutamine, 1 mM sodium pyruvate, 10 µg/mL penicillin and streptomycin, and 2% B27 supplement (Life Technologies) (culture medium). After 4 days, cytosine arabinoside (Sigma, 3 µM final concentration) was added to suppress glial cell proliferation. Cultures were fed twice a week by adding a quarter of the volume of fresh culture medium (after removal of the same volume). At DIV 15 th , neurons were incubated in culture medium (MEM 1X (Life Technologies), HEPES buffer 1M 1,5%
Portelius et al.
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Triazine herbicides induce Amyloid-β42 production S3 (Life Technologies) and NaOH (Sigma) up to pH 7,3) containing 100 µM herbicides or 100 µM aftin-5 (ManRos Therapeutics, Roscoff, France) or vehicle (0,1% sterile DMSO, Sigma) for 18 hours. At the end of the treatment, secreted Aβ 38 , Aβ 40 and Aβ 42 peptides in conditioned medium were quantified by a sandwich immunoassay using the Meso Scale Discovery SECTOR Imager 2400. All reagents were from Meso Scale Discovery (Rockeville MD, USA).
Human iPSCs-derived neuronal cultures
Induced pluripotent stem cells (iPSCs) from 33-year old healthy male (AβPP WT, wildtype) and 55-year old female harboring a lysine 724 to asparagine mutation in AβPP (AβPP K724N mutation) have been generated and characterized previously [37, 38] . From iPSCs we generated long-term self-renewing neuroepithelial stem cells (lt-NES cells), a homogeneous population which can be continuously propagated in the presence of FGF2 and EGF. To that end, 4-day-old embryoid bodies were transferred to polyornithine-coated tissue culture dishes and propagated in N2 medium (DMEM/F12 high glucose; N2 supplement, both Life Technologies, Darmstadt, Germany). Within 10 days, neural island consisting of neural rosettes and neural tube-like structures developed in the embryoid body outgrowth. These islands were mechanically isolated by separation from the surrounding cells with a scalpel. Isolated clusters where further propagated for 2 days as free-floating neurospheres in N2 medium containing 10 ng/mL FGF2 and 10 ng/mL EGF (both R&D Systems, Wiesbaden, Germany) and 1 µL/mL B27 Supplement (Life Technologies; short: N2 FEB medium). Spheres were triturated into single cells by incubating the spheres with trypsin/EDTA for 10 min followed by gentle dissociation with a 1.000 µL pipette tip. Cells were plated on polyornithine (Sigma Aldrich) and laminin (Life Technologies) precoated plastic dishes. Passaging of the cells was performed when cells had reached full confluence (normally every 3-4 days) at a 1:2 -1:3 ratio using trypsin/EDTA. Medium was changed every other day while growth factors were added on a daily basis.
Neuronal differentiation was performed by plating 300,000 and 1,000,000 cells per well of a Geltrex (Life Technologies; diluted 1:50)-precoated 12-well plate or 6-well plate, respectively, in N2 FEB medium. The following day, the medium was changed to terminal differentiation medium containing DMEM/F12 and MACS Neuro Medium (Miltenyibiotec, Bergisch Gladbach, Germany) mixed at a 1:1 ratio and supplemented with 1:200 N2 supplement, 1:100 B27 supplement and 300 ng/mL cAMP (Sigma Aldrich). Medium was changed every other day.
Compound treatment was performed on neuronal cultures differentiated for at least 4 weeks. Cells were pretreated for 16 h with compound containing medium (all compounds at 100 µM in 500 µL medium/ 12-well plate and 1,5 ml medium/ 6-well plate). Solvent only (DMSO) was used as control. Medium was replaced (same volume with freshly added compounds) and supernatants and lysates were harvested 24 h later. Supernatants were directly frozen in liquid nitrogen until analyzed. Aβ 42 and Aβ 40 in the supernatants were analyzed by ELISA (Meso Scale Discovery, Rockeville MD, USA) and normalized to the protein content of the cell pellet.
HEK293-alcadeinα cell culture and Alcadein fragments analysis
The full-length human Alcadeinα1 (Alcα) open reading frame [24] was subcloned into the HindIII and XbaI sites of pcDNA3.1 (Hygro+) vector (Invitrogen/Thermo Fisher Scientific, Portelius et al.
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Carlsbad, CA), transfected into HEK293 cells with Lipofectamine 2000 (Invitrogen/Thermo Fisher Scientific, Carlsbad, CA), and cells stably expressing Alcα were cloned. The cells cultured in dish coated with poly-L-lysine were treated with Aftin-5 or triazines (100 µM) for 24 h. The secreted p3-Alcα were recovered from the cultured medium by immunoprecipitation with anti-p3-Alcα UT175 antibody, an antibody raised to an antigen peptide composed of Cys plus the human Alcα1 839-851 sequence, using Protein G-Sepharose beads (GE Healthcare, Little Chalfont, UK). The beads were sequentially washed and samples were eluted with trifluoroacetic acid/acetonitrile/water (1:20:20) saturated with sinapinic acid, and subject to MALDI-TOF-MS analysis using an Ultraflex II TOF/TOF (Bruker Daltonics, Bremen, Germany). Molecular masses were calibrated using the peptide calibration standard (Bruker Daltonics) [25].
Transient transfections with AβPP truncation mutants
We used the human APP cDNA for all the experiments presented and the truncation mutants were generated by PCR using standard molecular techniques. Briefly, full-length human APP cDNA was previously subcloned by using standard PCR and TA cloning molecular techniques, into the pcDNA3.1(+) plasmid (Invitrogen, Carlsbad, CA) at BglII/BstXI restriction sites. Truncated APP mutants were subcloned from TA by EcoR1/EcoR1 restriction sites into APP containing pcDNA3.1 (+) plasmid.
Forward oligonucleotide for: T1-T6: 5'-TAT ATA AGA TCT CTG AAG TGA AGA TGG ATG C-3'
Reverse oligonucleotides for: T1: 5'-TAT ATA CCA GAC TAC TGG CTA GGT GAC AGC GGC GTC AAC-3' T2: 5'-TAT ATA CCA GAC TAC TGG CTA CAC ACC ATG ATG AAT GGA-3' T3: 5'-TAT ATA CCA GAC TAC TGG CTA CTG TTT CTT CTT CAG CAT -3' T4: 5'-TAT ATA CCA GAC TAC TGG CTA CAG CAT CAC CAA GGT GAT-3' T5: 5'-TAT ATA CCA GAC TAC TGG CTA CAC CAA GGT GAT GAC GAT -3' T6: 5'-TAT ATA CCA GAC TAC TGG CTA CAA GGT GAT GAC GAT CAC -3' N2a cells were maintained in growing medium (50% DMEM, 50% OPTI-MEM) supplemented with 5% fetal bovine serum (vol/vol). Transfections were carried using Fugene6 according to the manufacturer instructions. For experiments, cells were plated in 6-well plates at a density of 4 × 10 5 cells per well. Cells were grown to about 40% confluence and then transfected with relevant plasmid constructs using FuGENE6 (Roche, Indianapolis). 48 h after transfection, cells were treated for 24 h with various triazines. Supernatants were collected for Aβ42 measurements and cells were harvested for protein quantification.
Amyloids assays
Amyloids were measured by different methods according to the different cell types: -Primary rat neuronal cultures and human iPSCs-derived neuronal cultures: Meso Scale Discovery sandwich ELISA immunoassay. -N2a cells transfected with various APP C-terminal truncated mutants: BioSource International ELISA assay (see below). Table S3 . Effect of 21 products selected from a triazine library on extracellular Amyloid Aβ 42 production by N2a-APP695. N2a-APP695 cells were first treated with 10 and 100 µM of 236 triazines for 18 h and cell supernatant was collected for extracellular Aβ 42 levels measurement by an ELISA assay. The library was screened in triplicate, and active products (> 3 fold increase in Aβ42 production) were tested at 100 µM on N2a-APP695 cells in three independent experiments. Levels are expressed as fold change of Aβ 42 level over the Aβ 42 level of control, vehicle-treated cells. Average + errors bars represent standard error of triplicate values. *, 33 µM. Aftin-5 was used as positive control, and corresponding volume of vehicle (DMSO) was used as a negative control.
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